ApprovalTrail

Approval · Notice of Compliance 112 · 2003

AMCINONIDE: Notice of Compliance 112

Issued January 21, 2003

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
112
Date
January 21, 2003
Company
Glades, Division Of Stiefel Canada Inc.Montreal, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
New manufacturer and product name
Therapeutic class
Topical corticosteroid

Products in this notice

BrandDINStatus today
AMCINONIDE02247098Cancelled Post Market
AMCINONIDE02247097Cancelled Post Market
AMCINONIDE02247096Cancelled Post Market

Medicinal ingredients